One-year Mortality Among Unselected Outpatients with Heart Failure
Overview
Authors
Affiliations
Objective: To estimate 1-year mortality and prognostic factors in unselected outpatients with heart failure, and to compare the observed mortality with the estimates of the primary care physicians.
Methods And Results: Four hundred and eleven consecutive patients with heart failure New York Heart Association (NYHA) class II-IV (mean population age 75 years, 56% males) were enrolled in 71 primary care offices throughout Switzerland. During a mean follow-up period of 1.4 years, 68 patients had died. One-year total mortality was 12.6% compared to 4.3% in the underlying Swiss population (standardized mortality ratio 3.0). Among patients with heart failure NYHA II, III and IV, mortality was 7.1%, 15.0% and 28.0%, respectively. In multivariate Cox regression, statistically significant (P<0.05) predictors of mortality were NYHA class (NYHA III: risk ratio [RR]=1.6; NYHA IV: RR=2.2), recent hospital stay for heart disease (RR=2.3), creatinine>120 micromol.l(-1) (RR=1.8) systolic blood pressure<100 mmHg (RR=2.4), heart rate>100 min(-1) (RR=2.7), age (per 10 years, RR=1.6) and female gender (RR=0.49). Among patients with reduced left ventricular ejection fraction, 1-year mortality was 14.3%, and predictors were similar except that female gender was no longer associated with reduced mortality. Primary care physicians significantly overestimated 1-year mortality (estimated mortality 25.9% vs observed mortality 12.6%,P =0.001).
Conclusions: Unselected outpatients with heart failure have a poor prognosis, particularly those with advanced heart failure and a recent hospital stay for heart disease. Primary care physicians are aware of the high mortality of this growing patient population.
Torres Y, Benitez D, Morillo Z, Salazar J, Contreras-Velasquez J, Bermudez V J Clin Med. 2025; 14(2).
PMID: 39860650 PMC: 11765786. DOI: 10.3390/jcm14020644.
Hanna M, Fine N, Gundapaneni B, Sultan M, Witteles R JACC Adv. 2024; 1(5):100148.
PMID: 38939456 PMC: 11198604. DOI: 10.1016/j.jacadv.2022.100148.
Lazar-Poloczek E, Romuk E, Jachec W, Wrobel-Nowicka K, Swietek A, Wojciechowska C Biomedicines. 2024; 12(4).
PMID: 38672063 PMC: 11048168. DOI: 10.3390/biomedicines12040707.
Engster P, Zimerman A, Schaan T, Borges M, Souza G, Costa G Arq Bras Cardiol. 2023; 120(11):e20230077.
PMID: 38126514 PMC: 10773458. DOI: 10.36660/abc.20230077.
Prognostic Role of Metabolic Exercise Testing in Heart Failure.
Agdamag A, Van Iterson E, Tang W, Finet J J Clin Med. 2023; 12(13).
PMID: 37445473 PMC: 10342748. DOI: 10.3390/jcm12134438.